Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OptiMAx: Incentivizing EPI Vaccination Via Distribution of SQ-LNS Nutritional Supplementation to Children From Age 6-11 Months Until 18 Months of Age in Rural Chad and Niger, With a Cost Effectiveness Analysis Protocol for a Research Study Nested in the OptiMA Research Study in Ngouri Health District, Lake Region, Chad and Mirriah Health District, Zinder Region, Niger

NCT07592260 is registered in ClinicalTrials.gov with Alliance for International Medical Action as lead sponsor.

NCT NCT07592260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07592260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OptiMAx: Incentivizing EPI Vaccination Via Distribution of SQ-LNS Nutritional Supplementation to Children From Age 6-11 Months Until 18 Months of Age in Rural Chad and Niger, With a Cost Effectiveness Analysis Protocol for a Research Study Nested in the OptiMA Research Study in Ngouri Health District, Lake Region, Chad and Mirriah Health District, Zinder Region, Niger
Lead sponsor
Alliance for International Medical Action
Phase
Not applicable
Overall status
Recruiting
Start date
May 1, 2025
Completion date
December 31, 2026
Enrollment
20,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

malnutrition severe, vaccination